![Edwin Moses](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edwin Moses
Chairman at
AVANTIUM N.V.
Net worth: 132 256 $ as of 31/05/2026
Profile
Currently, Edwin Moses is Chairman at NanoSyrinx Ltd, Avantium NV, LabGenius Ltd., Achilles Therapeutics Plc, and Oak Hill Bio Corp., and Operating Partner at Keensight Capital SAS. Formerly, Dr. Moses was Chief Executive Officer & Director at Ablynx NV from 2014 to 2018, Chairman at Achilles Therapeutics UK Ltd. from 2018 to 2021, Non-Executive Chairman at Phoqus Pharmaceuticals Plc, Chairman at Capricorn Partners NV from 2009 to 2011, Chairman at Galapagos Biotech Ltd. from 2001 to 2006, Chairman at Oxford Asymmetry International Plc from 1993 to 2001, Non-Executive Chairman at ClinPhone Ltd., Chairman at Noapab Holdings A, Chairman at Paradigm Therapeutics Ltd. from 2004 to 2007, Non-Executive Chairman at Lectus Therapeutics Ltd., Non-Executive Chairman at Pharmaceutical Profiles Group Ltd. from 2005 to 2010, Chairman at ClinPhone Plc, Chairman at Proimmune Ltd., Chairman at Sensorion SA from 2020 to 2021, Chairman at Virion Biotherapeutics Ltd., Non-Executive Chairman at Evox Therapeutics Ltd. from 2018 to 2020, Non-Executive Director at Fusion IP Ltd. in 2009, Director at Evotec SE, Director at Hammersmith Imanet Ltd. from 1999 to 2000, Director at Ionix Pharmaceuticals Ltd., Director at Avantium Technologies BV, Director at Oxford Drug Design Ltd. from 2001 to 2002, Director at The London Technology Network in 2002, Director at ProPharma Ltd., Director at Prolysis Ltd., Director at Capricorn Health-Tech Fund NV from 2011 to 2016, Director at European Biopharmaceutical Enterprises, Director at AMS Biotechnology Ltd. in 1993, and Principal at GE Healthcare Ltd. (United Kingdom).
Education includes undergraduate and doctorate degrees from The University of Sheffield.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVANTIUM N.V. 0.05% | 22/09/2025 | 13,057 ( 0.05% ) | 132 256 $ | 31/05/2026 |
Edwin Moses active positions
| Companies | Position | Start |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Chairman | - |
| AVANTIUM N.V. | Chairman | 20/12/2019 |
Labgenius Ltd.
 Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Develops next-generation protein therapeutics using artificial intelligence, automation and synthetic DNA | Chairman | 20/04/2020 |
Keensight Capital SAS
 Keensight Capital SAS Investment ManagersFinance Keensight is an active manager which focuses on investments in innovative technologies. They invest in companies based on Information and Communications Technologies, particularly as applied to network throughput improvement, networks interconnectivity and convergence, network safety, data storage management and logistics. They have invested in software companies, semi conductors and telecommunications, as well as in medical technology. Their geographic focus is on Europe and particularly France. The firm favors mature businesses and generally participates in second and subsequent financing rounds. They target companies with proven technology, an already established clientele, a leading market position and high-growth potential. They promote the international expansion of their investee companies. | Private Equity Investor | 02/06/2020 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Chairman | 12/04/2022 |
NanoSyrinx Ltd
 NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel system for targeted delivery of therapeutic proteins and peptides | Chairman | - |
Former positions of Edwin Moses
| Companies | Position | End |
|---|---|---|
| SENSORION | Chairman | 19/12/2021 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Chairman | 11/01/2021 |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Chairman | 14/05/2020 |
| ░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Edwin Moses
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
36
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 36 |
|---|---|
Fusion IP Ltd.
 Fusion IP Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company, which engages in the commercialization of intellectual properties that is developed at universities and similar establishments | Commercial Services |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions. | Finance |
Hammersmith Imanet Ltd. | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops analgesic medicines | Health Technology |
ClinPhone Ltd.
 ClinPhone Ltd. Medical/Nursing ServicesHealth Services Provides outsourcing services to pharmaceutical companies and new drugs testing services to clinical research organisations | Health Services |
Avantium Technologies BV
 Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Process Industries |
Noapab Holdings A/S
 Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Technology Services |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
The London Technology Network
 The London Technology Network Other Consumer ServicesConsumer Services Provides academic training in computer science, life science, and physical science | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Profiles Group Ltd.
 Pharmaceutical Profiles Group Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for pharmaceutical and biotech companies | Health Technology |
ClinPhone Plc
 ClinPhone Plc Packaged SoftwareTechnology Services Provides on-line clinical solutions | Technology Services |
ProPharma Ltd.
 ProPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in pharmaceutical research and manufactures clinical trial supplies | Commercial Services |
Keensight Capital SAS
Keensight Capital SAS Investment ManagersFinance Keensight is an active manager which focuses on investments in innovative technologies. They invest in companies based on Information and Communications Technologies, particularly as applied to network throughput improvement, networks interconnectivity and convergence, network safety, data storage management and logistics. They have invested in software companies, semi conductors and telecommunications, as well as in medical technology. Their geographic focus is on Europe and particularly France. The firm favors mature businesses and generally participates in second and subsequent financing rounds. They target companies with proven technology, an already established clientele, a leading market position and high-growth potential. They promote the international expansion of their investee companies. | Finance |
Prolysis Ltd.
 Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
Proimmune Ltd.
 Proimmune Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes drugs | Health Technology |
Avantium NV
 Avantium NV Industrial MachineryProducer Manufacturing Engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development | Producer Manufacturing |
Capricorn Health-Tech Fund NV
 Capricorn Health-Tech Fund NV Investment ManagersFinance Functions as a private equity fund | Finance |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Labgenius Ltd.
Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Develops next-generation protein therapeutics using artificial intelligence, automation and synthetic DNA | Health Technology |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Engages in research in biotechnology for developing therapies for respiratory viral infections | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
AMS Biotechnology Ltd. | |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
NanoSyrinx Ltd
NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel system for targeted delivery of therapeutic proteins and peptides | Commercial Services |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Commercial Services |
- Stock Market
- Insiders
- Edwin Moses
